Gaudium IVF & Women Health IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Feb 20 to Feb 24 2026
Price Band
₹75 - 79
Current GMP
₹83.0 (+5.06%)
Subscription
7.27 times
IPO Details
| IPO Date | 20 to 24 Feb, 2026 |
| Listing Date | Fri, Feb 27, 2026 |
| Face Value | ₹ 5 per share |
| Price Band | ₹75 to ₹79 |
| Issue Price | ₹79 per share |
| Lot Size | 189 Shares |
| Sale Type | Fresh Capital & OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 2,08,86,200 shares (agg. up to ₹ 165 Cr) |
| Fresh Issue | 1,13,92,500 shares (agg. up to ₹ 90 Cr) |
| Offer for Sale | 94,93,700 shares of ₹ 5 (agg. up to ₹ 75 Cr) |
| Share Holding Pre Issue | 6,13,94,384 shares |
| Share Holding Post Issue | 7,27,86,884 shares |
| BSE Script Code / NSE Symbol | 544709 / |
| ISIN | INE0P8B01020 |
IPO Date
20 to 24 Feb, 2026
Listing Date
Fri, Feb 27, 2026
Face Value
₹ 5 per share
Price Band
₹75 to ₹79
Issue Price
₹79 per share
Lot Size
189 Shares
Sale Type
Fresh Capital & OFS
Issue Type
Bookbuilding IPO
Listing At
BSE, NSE
Total Issue Size
2,08,86,200 shares (agg. up to ₹ 165 Cr)
Fresh Issue
1,13,92,500 shares (agg. up to ₹ 90 Cr)
Offer for Sale
94,93,700 shares of ₹ 5 (agg. up to ₹ 75 Cr)
Share Holding Pre Issue
6,13,94,384 shares
Share Holding Post Issue
7,27,86,884 shares
BSE Script Code / NSE Symbol
544709 /
ISIN
INE0P8B01020
IPO Subscription Details
| Anchor | 1 |
| QIB (Ex Anchor) | 1.62 |
| NII | 14.05 |
| bNII (> ₹10L) | 12.71 |
| sNII (< ₹10L) | 16.73 |
| Retail | 7.60 |
| Total ** | 7.27 |
Anchor
1
QIB (Ex Anchor)
1.62
NII
14.05
bNII (> ₹10L)
12.71
sNII (< ₹10L)
16.73
Retail
7.60
Total **
7.27
Day Wise Sub
| Day | QIB (Ex Anchor) | NII | NII (> ₹10L) | NII (< ₹10L) | Retail | Total |
|---|---|---|---|---|---|---|
| Feb 2 0 (Day 1) | 0.00 | 0.91 | 0.54 | 1.65 | 1.42 | 0.90 |
| Feb 2 3 (Day 2) | 0.02 | 4.64 | 3.52 | 6.87 | 4.06 | 3.03 |
| Feb 2 4 (Day 3) | 1.62 | 14.05 | 12.71 | 16.73 | 7.60 | 7.27 |
DayFeb 2
0 (Day 1)
QIB (Ex Anchor)0.00
NII0.91
NII (> ₹10L)0.54
NII (< ₹10L)1.65
Retail1.42
Total0.90
DayFeb 2
3 (Day 2)
QIB (Ex Anchor)0.02
NII4.64
NII (> ₹10L)3.52
NII (< ₹10L)6.87
Retail4.06
Total3.03
DayFeb 2
4 (Day 3)
QIB (Ex Anchor)1.62
NII14.05
NII (> ₹10L)12.71
NII (< ₹10L)16.73
Retail7.60
Total7.27
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 27-02-2026 | 79.00 | 0(0.00%) | 79 |
| 26-02-2026 | 79.00 | 0(0.00%) | 79 |
| 25-02-2026 | 79.00 | -4(-5.06%) | 75 |
| 24-02-2026 | 79.00 | 0(0.00%) | 79 |
| 23-02-2026 | 79.00 | 5(6.33%) | 84 |
| 22-02-2026 | 79.00 | 8.5(10.76%) | 87.5 |
| 21-02-2026 | 79.00 | 8.5(10.76%) | 87.5 |
| 20-02-2026 | 79.00 | 8(10.13%) | 87 |
| 19-02-2026 | 79.00 | 8.5(10.76%) | 87.5 |
| 18-02-2026 | 79.00 | 12(15.19%) | 91 |
| 17-02-2026 | 79.00 | 15(18.99%) | 94 |
| 16-02-2026 | 0(0.00%) | (0.00%) | |
| 15-02-2026 | 0(0.00%) | (0.00%) | |
| 14-02-2026 | 0(0.00%) | (0.00%) | |
| 13-02-2026 | 0(%) | (%) |
Date27-02-2026
Price79.00
GMP0(0.00%)
Estimate List Price79
Date26-02-2026
Price79.00
GMP0(0.00%)
Estimate List Price79
Date25-02-2026
Price79.00
GMP-4(-5.06%)
Estimate List Price75
Date24-02-2026
Price79.00
GMP0(0.00%)
Estimate List Price79
Date23-02-2026
Price79.00
GMP5(6.33%)
Estimate List Price84
Date22-02-2026
Price79.00
GMP8.5(10.76%)
Estimate List Price87.5
Date21-02-2026
Price79.00
GMP8.5(10.76%)
Estimate List Price87.5
Date20-02-2026
Price79.00
GMP8(10.13%)
Estimate List Price87
Date19-02-2026
Price79.00
GMP8.5(10.76%)
Estimate List Price87.5
Date18-02-2026
Price79.00
GMP12(15.19%)
Estimate List Price91
Date17-02-2026
Price79.00
GMP15(18.99%)
Estimate List Price94
Date16-02-2026
Price
GMP0(0.00%)
Estimate List Price(0.00%)
Date15-02-2026
Price
GMP0(0.00%)
Estimate List Price(0.00%)
Date14-02-2026
Price
GMP0(0.00%)
Estimate List Price(0.00%)
Date13-02-2026
Price
GMP0(%)
Estimate List Price(%)
IPO Important Dates
| IPO Open | Fri, Feb 20, 2026 |
| IPO Close | Tue, Feb 24, 2026 |
| Allotment | Wed, Feb 25, 2026 |
| Refund | Wed, Feb 25, 2026 |
| Credit of Shares | Thu, Feb 26, 2026 |
| Listing | Fri, Feb 27, 2026 |
IPO Open
Fri, Feb 20, 2026
IPO Close
Tue, Feb 24, 2026
Allotment
Wed, Feb 25, 2026
Refund
Wed, Feb 25, 2026
Credit of Shares
Thu, Feb 26, 2026
Listing
Fri, Feb 27, 2026
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 189 | ₹14,931 |
| Retail (Max) | 13 | 2,457 | ₹1,94,103 |
| S-HNI (Min) | 14 | 2,646 | ₹2,09,034 |
| S-HNI (Max) | 66 | 12,474 | ₹9,85,446 |
| B-HNI (Min) | 67 | 12,663 | ₹10,00,377 |
ApplicationRetail (Min)
Lots1
Shares189
Amount₹14,931
ApplicationRetail (Max)
Lots13
Shares2,457
Amount₹1,94,103
ApplicationS-HNI (Min)
Lots14
Shares2,646
Amount₹2,09,034
ApplicationS-HNI (Max)
Lots66
Shares12,474
Amount₹9,85,446
ApplicationB-HNI (Min)
Lots67
Shares12,663
Amount₹10,00,377
Key Performance Indicator
| ROE | 21.25% |
| ROCE | 21.03% |
| Debt/Equity | 0.38 |
| RoNW | 21.34% |
| PAT Margin | 25.14% |
| EBITDA Margin | 38.29% |
| Price to Book Value |
ROE
21.25%
ROCE
21.03%
Debt/Equity
0.38
RoNW
21.34%
PAT Margin
25.14%
EBITDA Margin
38.29%
Price to Book Value
Peers Comparison
| Company Name | EPS (Basic) | NAV (₹ per share) | P/E (x) | RoNW (%) | P/BV Ratio |
|---|---|---|---|---|---|
| Gaudium IVF and Women Health | 3.12 | 7.54 | 41.71 | ||
| Progyny Inc. | 50.52 | 394.20 | 41.56 | 12.90 | 5.33 |
| Inspire IVF Public Company | 0.17 | 4.34 | 11.43 | 3.97 | 0.25 |
Company NameGaudium IVF and Women Health
EPS (Basic)3.12
NAV (₹ per share)7.54
P/E (x)
RoNW (%)41.71
P/BV Ratio
Company NameProgyny Inc.
EPS (Basic)50.52
NAV (₹ per share)394.20
P/E (x)41.56
RoNW (%)12.90
P/BV Ratio5.33
Company NameInspire IVF Public Company
EPS (Basic)0.17
NAV (₹ per share)4.34
P/E (x)11.43
RoNW (%)3.97
P/BV Ratio0.25
IPO Reservation
| QIB Shares Offered | 1,04,43,100 (50.00%) |
| − Anchor Investor Shares Offered | 62,65,860 (30.00%) |
| − QIB (Ex. Anchor) Shares Offered | 41,77,240 (20.00%) |
| NII (HNI) Shares Offered | 31,32,930 (15.00%) |
| − bNII > ₹10L | 20,88,620 (10.00%) |
| − sNII < ₹10L | 10,44,310 (5.00%) |
| Retail Shares Offered | 73,10,170 (35.00%) |
| Total Shares Offered | 2,08,86,200 (100.00%) |
QIB Shares Offered
1,04,43,100 (50.00%)
− Anchor Investor Shares Offered
62,65,860 (30.00%)
− QIB (Ex. Anchor) Shares Offered
41,77,240 (20.00%)
NII (HNI) Shares Offered
31,32,930 (15.00%)
− bNII > ₹10L
20,88,620 (10.00%)
− sNII < ₹10L
10,44,310 (5.00%)
Retail Shares Offered
73,10,170 (35.00%)
Total Shares Offered
2,08,86,200 (100.00%)
Information about company
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India and have expanded into several states utilizing a hub-and-spoke model.
The company operates over thirty locations, which include seven hubs (centres) and twenty-eight spokes. The organization has entered into a strategic alliance with Infertility Experts, known as Spokes, to achieve the mutual objective of raising awareness regarding Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) treatments.
The company serves patients from various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The company has centres in major cities: two in Delhi (Janakpuri, Kailash Colony), and one each in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore, covering key locations across India.
The company offers specialized fertility services, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction. The company's treatments are designed for various infertility challenges for both genders. The company also provide comprehensive gynaecological care for PCOD/PCOS and endometriosis, as well as high-risk pregnancy management for women with complex fertility histories or health conditions.
Objectives of IPO
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Funding capital expenditure towards establishment of New IVF Centers of the Company. 50.00 2 Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company. 20.00 3 General Corporate Purpose Total 70.00
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App